New developments of brain imaging for Parkinson's Disease and related disorders

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review


Parkinson's disease (PD) and related disorders are subcortical degenerations targeting the nigrostriatal dopaminergic system and basal ganglia. Traditionally, MRI has been used to detect structural and positron emission tomography and single emission computed tomography functional neurochemical and metabolic changes associated with these disorders. Recently, advances in diffusion-weighted MRI, ultrasonography, and radiotracer-based imaging have yielded greater sensitivity for revealing structural change and allowed detection of changes in brain dopamine levels after levodopa and during behavioral tasks. This review focuses on these recent advances in neuroimaging technology and their use for the diagnosis and assessment of PD and othe kinsonian disorders.

Original languageEnglish
JournalMovement Disorders
Pages (from-to)2035-2041
Number of pages7
Publication statusPublished - 1 Dec 2006
Externally publishedYes

    Research areas

  • Functional imaging, Movement disorders, Parkinson's disease

See relations at Aarhus University Citationformats

ID: 130776480